Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Zonagen and Schering-Plough to forego FDA advisory panel review of Vasomax NDA

May 11, 1999

EMEA approves new formulation of Organon's fertility drug Puregon

May 11, 1999

Oral fenoldopam useful for delaying progression of diabetic nephropathy

May 11, 1999

Takeda receives clearance to market lipid-lowering statin in Japan

May 11, 1999

Phase I trial results reported for GA-EPO at nephrology congress

May 10, 1999

IND exemption granted to Polydex's STD/contraceptive drug

May 10, 1999

Sublingual apomorphine aids in erectile dysfunction

May 10, 1999

Natural insulin-sensitizing agent may help cure PCOS infertility

May 10, 1999

PDE4 inhibitor XT-44 inhibits bone loss in animal models of osteopenia

May 7, 1999

New prostaglandin F analogues from P&G targeted for bone disorders, glaucoma

May 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...